Brief: Fulgent Genetics Awarded Contract From CDC To Study Variants Of Covid-19 Virus
15/03/2021 20:33
March 15 (Reuters) - Fulgent Genetics Inc FLGT.O :
* FULGENT GENETICS AWARDED CONTRACT FROM CDC TO STUDY
VARIANTS OF
COVID-19 VIRUS
* FULGENT GENETICS - UNDER AGREEMENT, CO WILL SEQUENCE
GENOMES OF
RANDOM SAMPLES THAT HAVE TESTED POSITIVE FOR SARS-COV-2, VIRUS
THAT CAUSES COVID-19
Source text for Eikon: ID:nGNX90PPD0
Further company coverage: FLGT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fulgent Genetics
See all newsU.S. RESEARCH ROUNDUP-Cloudflare, Replimune, Walmart
Fulgent Genetics Inc reports results for the quarter ended June 30 - Earnings Summary
Fulgent Genetics Q2 revenue rises 20% sequentially, sees billing system transition delay
Brief: Fulgent Genetics Q2 Revenue USD 85.389 Million
Fulgent Genetics Inc expected to post a loss of 46 cents a share - Earnings Preview